The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

Purdue Pharma and the members of the Sackler family who own the company agreed in principle to pay a $7.4 billion settlement to resolve thousands of lawsuits over their alleged role in the opioid ...

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma ... U.S. Supreme Court overturned ...

The yearslong bankruptcy case could be coming to a close. Purdue Pharma’s owners in the Sackler ... a previous deal was rejected by the Supreme Court last year. We’ll break down the details ...

The new settlement reopens a path to ending Purdue’s chapter 11 case, the longest and costliest corporate bankruptcy stemming ...

Purdue Pharma and Sackler family agree to a $7.4 billion settlement over opioid crisis lawsuits, pending court approval ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

Purdue Pharma and the members of the Sackler family ... which was invalidated by the Supreme Court last June due to a provision in the deal immunizing some members of the wealthy Sackler family ...